Aripiprazole in childhood and adolescence for Tourette syndrome [3]

Journal of Child Neurology

Volumn 21, Issue 4, 2006, Pages 358-

  Duane, Drake D ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE;

AKATHISIA; ATTENTION; BODY WEIGHT DISORDER; CHILD BEHAVIOR; CHILD CARE; COGNITION; DISEASE CONTROL; FOLLOW UP; GILLES DE LA TOURETTE SYNDROME; HUMAN; LETTER; NAUSEA; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; WEIGHT GAIN;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; ANTIPSYCHOTIC AGENTS; ATTENTION; BODY WEIGHT; CHILD; CHILD BEHAVIOR; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PIPERAZINES; PSYCHOMOTOR AGITATION; QUINOLONES; TOURETTE SYNDROME; TREATMENT OUTCOME;

EID: 33745150047     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.2310/7010.2006.00083     Document Type: Letter

References (2)

1. Rugino TA, Janvier YM: Aripiprazole in children and adolescents: Clinical experience. J Child Neurol 2005;20:603-610.
2. Duane DD, Heimburger GE, Flecky SA, et al: Open-label flexible dosing 8-week trial of aripiprazole in Tourette syndrome children/adolescents/ young adults. Presented at the American Neuropsychiatric Association meeting, La Jolla, CA, February 18-21, 2006.